32957037 18634811 32092625 18725236 18851999 21306831 20196742 34247265 21948099 31009632 36709036 21216239 32388620 18614026 - Search Results

Year	Number of Results
2008	4
2009	1
2010	1
2011	3
2019	1
2020	3
2021	1
2023	1

1

Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?

Gold MS, Baron D, Bowirrat A, Blum K. Gold MS, et al. J Neurol Sci. 2020 Nov 15;418:117137. doi: 10.1016/j.jns.2020.117137. Epub 2020 Sep 15. J Neurol Sci. 2020. PMID: 32957037 Free PMC article. Review.

2

Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats.

Liu J, Pan H, Gold MS, Derendorf H, Bruijnzeel AW. Liu J, et al. Neuropharmacology. 2008 Oct;55(5):812-8. doi: 10.1016/j.neuropharm.2008.06.034. Epub 2008 Jun 27. Neuropharmacology. 2008. PMID: 18634811

3

Medication-assisted therapies for opioid use disorders in patients with chronic pain.

Oesterle TS, Kolla BP, Rummans TA, Gold MS. Oesterle TS, et al. J Neurol Sci. 2020 Apr 15;411:116728. doi: 10.1016/j.jns.2020.116728. Epub 2020 Feb 11. J Neurol Sci. 2020. PMID: 32092625 Review.

4

Neurobiological substrates for the dark side of compulsivity in addiction.

Koob GF. Koob GF. Neuropharmacology. 2009;56 Suppl 1(Suppl 1):18-31. doi: 10.1016/j.neuropharm.2008.07.043. Epub 2008 Aug 7. Neuropharmacology. 2009. PMID: 18725236 Free PMC article. Review.

5

Endogenous opiates and behavior: 2007.

Bodnar RJ. Bodnar RJ. Peptides. 2008 Dec;29(12):2292-375. doi: 10.1016/j.peptides.2008.09.007. Epub 2008 Sep 21. Peptides. 2008. PMID: 18851999 Review.

6

Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.

Blum K, Gold MS. Blum K, et al. Med Hypotheses. 2011 Apr;76(4):576-84. doi: 10.1016/j.mehy.2011.01.005. Med Hypotheses. 2011. PMID: 21306831

7

Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors.

López-Moreno JA, López-Jiménez A, Gorriti MA, de Fonseca FR. López-Moreno JA, et al. Curr Drug Targets. 2010 Apr;11(4):406-28. doi: 10.2174/138945010790980312. Curr Drug Targets. 2010. PMID: 20196742 Review.

8

Comparative benefits of social housing and buprenorphine on wheel running depressed by morphine withdrawal in rats.

Stickney JD, Morgan MM. Stickney JD, et al. Psychopharmacology (Berl). 2021 Oct;238(10):2895-2903. doi: 10.1007/s00213-021-05906-8. Epub 2021 Jul 10. Psychopharmacology (Berl). 2021. PMID: 34247265

9

Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?

Blum K, Chen TJ, Bailey J, Bowirrat A, Femino J, Chen AL, Simpatico T, Morse S, Giordano J, Damle U, Kerner M, Braverman ER, Fornari F, Downs BW, Rector C, Barh D, Oscar-Berman M. Blum K, et al. Mol Neurobiol. 2011 Dec;44(3):250-68. doi: 10.1007/s12035-011-8206-0. Epub 2011 Sep 24. Mol Neurobiol. 2011. PMID: 21948099 Free PMC article.

10

Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.

Jordan CJ, Cao J, Newman AH, Xi ZX. Jordan CJ, et al. Neuropharmacology. 2019 Nov 1;158:107609. doi: 10.1016/j.neuropharm.2019.04.015. Epub 2019 Apr 19. Neuropharmacology. 2019. PMID: 31009632 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year